Results 181 to 190 of about 12,661 (240)

Metabolic Profiling of Circulating and Tumour‐Infiltrating T Cells Uncovers Bioenergetic Checkpoints Linked With Immune and Clinical Skewing in Melanoma Patients

open access: yesImmunology, Volume 179, Issue 3, Page 486-515, November 2026.
In this study, we revealed the disturbed metabolic status of circulating and tumour‐infiltrating CD4+ and CD8+ T cells in melanoma patients through targeted metabolomic and lipidomic (on sorted subsets) and at single cell level using the SCENITH method.
Hugo Brouque   +11 more
wiley   +1 more source

A Randomized, Double‐Blind, Placebo‐Controlled Study of the PD‐1 Inhibitor Cetrelimab in Chronic Hepatitis B

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 11, November 2026.
ABSTRACT Hepatitis B virus (HBV)‐induced T‐cell exhaustion may be reversed using a programmed death receptor 1 (PD‐1) inhibitor such as cetrelimab, an investigational fully human monoclonal antibody targeting PD‐1. To evaluate the safety, activity and pharmacokinetics of low‐dose (i.e., a dose lower than that used in oncology) cetrelimab in ...
Tarik Asselah   +10 more
wiley   +1 more source

Azole‐Resistant Aspergillosis: An Emerging Diagnostic and Therapeutic Challenge in Paediatrics

open access: yesMycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Introduction Invasive aspergillosis (IA) represents one of the most frequent invasive fungal infections in paediatric patients with risk factors. An increase in cases of azole‐resistant IA has been reported in adult patients. The aim of this study is to present a series of 11 cases of paediatric patients with this pathology.
Natalia Mendoza‐Palomar   +14 more
wiley   +1 more source

Stage‐Associated Collagen Gene Expression and Macrophage‐Associated Immune Features in Nail Unit Melanoma

open access: yesPigment Cell &Melanoma Research, Volume 39, Issue 6, November 2026.
Bulk RNA sequencing of 43 formalin‐fixed, paraffin‐embedded nail unit melanomas identified two transcriptomic groups associated with clinical stage. The early‐stage‐enriched group showed higher expression of epidermal adhesion and keratinocyte differentiation genes, whereas the late‐stage‐enriched group showed higher expression of melanocytic and ...
Yuri Sawada   +8 more
wiley   +1 more source

Corneal Xenotransplantation: Lessons From Allograft Immunobiology and Emerging Translational Strategies

open access: yesXenotransplantation, Volume 33, Issue 6, November/December 2026.
ABSTRACT Corneal transplantation is an effective sight‐restoring procedure, yet its global impact remains constrained by limited and uneven access to human donor tissue and by immune‐mediated graft failure, particularly in high‐risk recipients. Xenotransplantation offers a potentially scalable alternative, but successful clinical translation requires ...
Ansu A. John, Ellen H. Koo
wiley   +1 more source

CTLA4 polymorphisms and COPD.

open access: yes, 2016
Wood, A, Newby, P, Gough, S, Stockley, R
openaire   +1 more source

Abatacept for Treatment-Refractory Pediatric CTLA4-Haploinsufficiency

Clinical Immunology, 2021
CTLA4-haploinsufficiency is a complex disease of immune dysregulation presenting with a broad spectrum of clinical manifestations. CTLA4-Fc fusion proteins such as abatacept have been described to alleviate immune dysregulation in several adult cases of ...
Fabian Hauck   +2 more
exaly   +2 more sources

CTLA4-Ig: A Novel Immunosuppressive Agent

Expert Opinion on Investigational Drugs, 2000
Activation of naive T-cells requires two signals: one is antigen-specific and based on T-cell receptor (TCR) recognition of a peptide-MHC complex and the second is antigen-nonspecific and delivered by specific T-cell receptors after ligation with their ligands (costimulatory molecules) expressed by antigen-presenting cells (APCs).
Mohamed H Sayegh, Nader Najafian
exaly   +3 more sources

CTLA4-Ig mediated immunosuppression favors immunotolerance and restores graft in mouse airway transplants.

Pharmacological Research, 2022
CTLA4-Ig is a potent costimulatory blocker that inhibits T cell activation during alloimmune inflammation and increases graft survival and function.
M. Khan   +5 more
semanticscholar   +1 more source

Identification of discrepancy between CTLA4 expression and CTLA4 activation in gastric cancer

Immunopharmacology and Immunotoxicology, 2018
Objective: Recently, immune checkpoints blockers showed higher anti-tumor activity for advanced gastric cancer (GC). The purpose of the study is to find out predictive biomarkers related to anti-cytotoxic lymphocyte antigen 4 (CTLA4) therapy. Materials and methods: Datasets of gene expression omnibus (GEO), the cancer genome atlas (TCGA), and gene set ...
Zhen, Xiang   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy